VIR
Vir Biotechnology, Inc. Common StockstockNASDAQ
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world's most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 12.12 | 2026-11-12 | -24.59% | -3.531 |
| 1M | 10.21 | 2026-10-19 | -10.48% | 2.608 |
| 3M | 9.77 | 2026-08-19 | -6.45% | 2.563 |
| 6M | 8.53 | 2026-05-19 | +7.15% | 1.706 |
| 1Y | 5.44 | 2025-11-19 | +68.02% | 1.853 |
| 2Y | 6.93 | 2024-11-19 | +31.89% | — |
| 5Y | 32.75 | 2021-11-19 | -72.09% | 1.411 |
Vir Biotechnology, Inc. Common Stock (NASDAQ:VIR) stock price today is $9.14, and today's volume is 2,154,928. VIR is down 1.189% today. The 30 day average volume is 2.65M. VIR market cap is $1.70B with 186.27M shares outstanding.